Dropout and re-enrollment: Implications for epidemiological projections of treatment programs

AIDS

Volumn 28, Issue SUPPL. 1, 2014, Pages

  Klein, Daniel J ^a   Bershteyn, Anna ^a   Eckhoff, Philip A ^a  

^a Intellectual Ventures Laboratory   (United States)

Author keywords

Antiretroviral Therapy Treatment Guidelines; Computer Model; EMOD; Epidemiology; HIV; Sensitivity Analysis

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CD4 LYMPHOCYTE COUNT; COST EFFECTIVENESS ANALYSIS; FEASIBILITY STUDY; FOLLOW UP; HEALTH CARE; HEALTH CARE COST; HEALTH PROGRAM; HUMAN; PATIENT CARE; PATIENT DROPOUTS; PRACTICE GUIDELINE; PRENATAL CARE; PRIORITY JOURNAL; SOUTH AFRICA;

ADOLESCENT; ADULT; AGED; ANTI-RETROVIRAL AGENTS; CHILD, PRESCHOOL; COST-BENEFIT ANALYSIS; DISEASE TRANSMISSION, INFECTIOUS; FEMALE; HIV INFECTIONS; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; PATIENT DROPOUTS; PREGNANCY; PROJECTION; SOUTH AFRICA; YOUNG ADULT;

EID: 84893244784     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0000000000000081     Document Type: Article

References (26)

1. Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med 2011; 365:493-505.
2. Donnell D, Baeten JM, Kiarie J, Thomas KK, Stevens W, Cohen CR, et al. Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: A prospective cohort analysis. Lancet 2010; 375:2092-2098.
3. Tanser F, Barnighausen T, Grapsa E, Zaidi J, Newell M-L. High coverage of ART associated with decline in risk of HIV acquisition in rural KwaZulu-Natal, South Africa. Science 2013; 339:966-971.
4. Boily M-C, Masse B, Alsallaq R, Padian NS, Eaton JW, Vesga JF, et al. HIV treatment as prevention: Considerations in the design, conduct, and analysis of cluster randomized controlled trials of combination HIV prevention. PLoS Med 2012; 9:e1001250.
5. Eaton JW, Johnson LF, Salomon JA, Barnighausen T, Bendavid E, Bershteyn A, et al. HIV treatment as prevention: Systematic comparison of mathematical models of the potential impact of antiretroviral therapy on HIV incidence in South Africa. PLoS Med 2012; 9:e1001245.
6. Bershteyn A, Klein DJ, Wenger E, Eckhoff PA. Description of the EMOD-HIV Model v0.7. arXiv:12063720 Published Online First: 16 June 2012. http://arxiv.org/abs/1206.3720. [Accessed 27 April 2013].
7. Eaton JW, Menzies NA, Stover J, Cambiano V, Chindelevitch L, Cori A, et al. Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: A combined analysis of 12 mathematical models. The Lancet Global Health Published Online First: December 2013. doi: 10. 1016/S2214-109X(13)70172-4.
8. Rosen S, Fox MP. Retention in HIV care between testing and treatment in Sub-Saharan Africa: A systematic review. PLoS Med 2011; 8:e1001056.
9. Pavie J, Rachline A, Loze B, Niedbalski L, Delaugerre C, Laforgerie E, et al. Sensitivity of five rapid HIV tests on oral fluid or finger-stick whole blood: A real-time comparison in a healthcare setting. PLoS One 2010; 5:e11581.
10. Bassett I, Chetty S, Giddy J, Reddy S, Bishop K, Lu Z, et al. Screening for acute HIV infection in South Africa: Finding acute and chronic diseaseM. HIV Med 2011; 12:46-53.
11. Shisana O, Council HSR, Evaluation C for AD, Research and, Council SAMR, Africa) NI for CD.(South. South African National HIV Prevalence, Incidence, Behaviour and Communication Survey, 2008: A turning tideamong teenagers HSRC Press; 2010.
12. Shisana O, Council HSR, Evaluation C for AD, Research and, Council SAMR, Africa) NI for CD.(South. South African National HIV Prevalence, Incidence, Behaviour and Communication Survey, 2008: A turning tide among teenagers HSRC Press; 2010.
13. April MD, Walensky RP, Chang Y, Pitt J, Freedberg KA, Losina E, et al. HIV testing rates and outcomes in a South African community, 2001-2006: Implications for expanded screening policies. J Acquir Immune Defic Syndr 2009; 51:310-316.
14. Kranzer K, Van Schaik N, Karmue U, Middelkoop K, Sebastian E, Lawn SD, et al. High prevalence of self-reported undiagnosed HIV despite high coverage of HIV testing: A cross-sectional population based sero-survey in South Africa. PLoS One 2011; 6:e25244.
15. Venkatesh KK, Madiba P, De Bruyn G, Lurie MN, Coates TJ, Gray GE. Who gets tested for HIV in a South African urban township Implications for test and treat and gender-based prevention interventions. J Acquir Immune Defic Syndr 2011; 56:151-165.
16. Doherty T, Chopra M, Nsibande D, Mngoma D. Improving the coverage of the PMTCT programme through a participatory quality improvement intervention in South Africa. BMC Public Health 2009; 9:406.
17. Adam MA, Johnson LF. Estimation of adult antiretroviral treatment coverage in South Africa. South Afr Med J 2009; 99:661-667.
18. Cornell M, Grimsrud A, Fairall L, Fox MP, Van Cutsem G, Giddy J, et al. Temporal changes in programme outcomes among adult patients initiating antiretroviral therapy across South Africa, 2002-2007. AIDS Lond Engl 2010; 24:2263-2270.
19. Cornell M, Schomaker M, Garone DB, Giddy J, Hoffmann CJ, Lessells R, et al. Gender differences in survival among adult patients starting antiretroviral therapy in South Africa: A multicentre cohort study. PLoS Med 2012; 9:e1001304.
20. Raftery AE, Bao L. Estimating and projecting trends in HIV/AIDS generalized epidemics using incremental mixture importance sampling. Biometrics 2010; 66:1162-1173.
21. McKay MD, Beckman RJ, Conover WJ. A comparison of three methods for selecting values of input variables in the analysis of output from a computer code. Technometrics 1979; 21:239.
22. Iman RL, Campbell JE, Helton JC. An approach to sensitivity analysis of computer models. Part I. Introduction, input, variable selection and preliminary variable assessment. J Qual Technol 1981; 13:174-183.
23. Hamers RL, Siwale M, Wallis CL, Labib M, Van Hasselt R, Stevens WS, et al. HIV-1 drug resistance mutations are present in six percentage of persons initiating antiretroviral therapy in Lusaka, Zambia. J Acquir ImmuneDefic Syndr 2010; 55:95-101.
24. Bae JW, Guyer W, Grimm K, Altice FL. Medication persistence in the treatment of HIV infection: A review of the literature and implications for future clinical care and research. AIDS 2011; 25:279-290.
25. Jani IV, Sitoe NE, Alfai ER, Chongo PL, Quevedo JI, Rocha BM, et al. Effect of point-of-care CD4 cell count tests on retention of patients and rates of antiretroviral therapy initiation in primary health clinics: An observational cohort study. Lancet 2011; 378:1572-1579.
26. Larson BA, Schnippel K, Ndibongo B, Xulu T, Brennan A, Long L, et al. Rapid point-of-care CD4 testing at mobile HIV testing sites to increase linkage to care. J Acquir Immune Defic Syndr 2012; 61:e13-e17.